| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |